In a landmark advancement for genome engineering, researchers have unveiled a transformative technique known as prime assembly (PA) that drastically improves the insertion of large DNA fragments into genomes. This development addresses a longstanding bottleneck in gene therapy and genetic manipulation—the efficient integration of extensive DNA sequences exceeding 400 base pairs. By capitalizing on the concept of twin prime-editing guide RNAs (pegRNAs), the PA approach introduces a sophisticated toolset that not only boosts the scale of insertable DNA but also enhances precision and efficiency in a manner previously unattainable.
Traditional prime editing methods had made strides in genome modifications but struggled when tasked with incorporating longer DNA fragments, often encountering steep declines in efficiency beyond 400 base pairs. The PA strategy circumvents these limitations by leveraging designed linear DNA donors featuring overlapping ends complementary to the single-stranded “flaps” generated by twin prime editing. This facilitates a cellular Gibson-like assembly mechanism, enabling seamless integration without the collateral damage associated with double-stranded DNA breaks or reliance on canonical homology-directed repair (HDR) pathways.
The implications of PA for gene therapy are profound. Insertions spanning from 0.1 kilobases (kb) to an unprecedented 11 kb were successfully introduced into the genome, far exceeding the capabilities of earlier prime editing techniques. Unlike traditional homologous recombination strategies that depend heavily on cycling cells and endogenous repair machinery, PA operates efficiently in non-dividing cells. This independence from HDR broadens the scope of cells amenable to precise genome engineering, including post-mitotic cells such as neurons, thus expanding the therapeutic landscape considerably.
A notable enhancement to PA’s efficiency was achieved through the application of a non-homologous end joining (NHEJ) inhibitor, which curtailed a predominant error-prone DNA repair pathway. By limiting NHEJ activity, the researchers observed not only greater insertion precision but also elevated overall editing efficiency. This inhibitory approach mitigates the competing pathways that typically diminish the fidelity and yield of large DNA fragment integration.
Critically, PA does not require the exogenous delivery of DNA-dependent DNA polymerases, a common necessity in other genome engineering approaches. This minimizes complexities related to enzyme delivery and potential immunogenicity. Instead, the cells harness their native enzymatic repertoire to facilitate the overlapping donor assembly in situ, representing a streamlined and potentially safer genome editing modality.
The research team systematically demonstrated the versatility of PA through a series of experiments involving the insertion of multiple overlapping DNA fragments. This modular insertion strategy paves the way for constructing intricate genetic circuits or restoring large gene segments in therapeutic contexts. Notably, the ability to engineer large genomic regions without introducing double-stranded breaks mitigates risks associated with chromosomal rearrangements or unintended mutagenesis.
Mechanistically, the PA method exploits the flaps generated during twin prime editing as anchoring sites where the linear DNA donors hybridize through complementary overlapping sequences. This molecular choreography primes the cellular machinery to assemble these fragments in a manner analogous to Gibson assembly, directly within the genome. This novel intracellular assembly process is a paradigm shift, illustrating that cells can be co-opted to perform complex DNA fragment ligations autonomously.
The absence of recombinase enzymes in PA further simplifies its application and decreases the potential for off-target enzymatic activities that could compromise genomic integrity. This attribute, combined with the method’s applicability in non-dividing cells, suggests broad utility across diverse cell types and tissues, including those previously challenging to edit effectively.
From a therapeutic standpoint, the PA technique may revolutionize the correction of monogenic disorders caused by large deletions or complex mutations that necessitate the insertion of sizeable genetic payloads. Moreover, it holds promise for synthetic biology applications requiring insertion of extensive regulatory elements or entire gene cassettes to reprogram cellular functions precisely.
Importantly, the linear DNA donor templates used in PA are amenable to facile production and customization, enhancing the practicality and scalability of the approach. Their design flexibility allows tailoring of the overlapping regions to optimize assembly efficiency and fidelity, granting researchers a powerful degree of control over editing outcomes.
In sum, the prime assembly strategy unveiled by Liu, Petti, Zhou, and colleagues represents a quantum leap in precise genome engineering. By enabling large, seamless DNA insertions without double-stranded breaks, recombinases, or reliance on homology-directed repair, PA expands the toolkit for genetic engineers and therapeutics developers alike. This breakthrough not only enhances editing efficiency and precision but fundamentally reimagines how cells can be co-opted for complex DNA assembly in vivo, heralding a new era for gene therapy and synthetic biology innovation.
Subject of Research: Not explicitly stated in the provided content.
Article Title: Prime assembly with linear DNA donors enables large genomic insertions.
Article References: Liu, B., Petti, A., Zhou, X. et al. Prime assembly with linear DNA donors enables large genomic insertions. Nature (2026). https://doi.org/10.1038/s41586-026-10460-4
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41586-026-10460-4
Keywords: genome engineering, prime editing, large DNA insertions, twin prime-editing guide RNAs, gene therapy, non-homologous end joining inhibition, homology-directed repair independence, Gibson assembly analogy, linear DNA donors, non-dividing cells, genome assembly, synthetic biology
